Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

CLIA - Clinical Laboratory Improvement Amendments
  • Print
  • Share
  • E-mail
-
1 to 6 of 6 Results
Document Number CR260307
Results per Page

New Searchexport reports to excelExport to Excel | HelpHelp
Document Parent Analyte Analyte Specialty Complexity Effective Date
Roche Diagnostics, cobas pro integrated solutions, cobas c 703  {LDL-Cholesterol Gen.3} 
CR260307 K143691 LDL cholesterol General Chemistry MODERATE 05/07/2026
Roche Diagnostics, cobas pro integrated solutions, cobas c 703  {Ammonia II} 
CR260307 K183517 Ammonia General Chemistry MODERATE 05/07/2026
Roche Diagnostics, cobas pro integrated solutions, cobas c 703  {Triglycerides} 
CR260307 K951595 Triglyceride General Chemistry MODERATE 05/07/2026
Roche Diagnostics, cobas pro integrated solutions, cobas c 703  {Unsaturated Iron-Binding Capacity} 
CR260307 K954992 Iron binding capacity, unsat. (UIBC) no pretreatment General Chemistry MODERATE 05/07/2026
Roche Diagnostics, cobas pro integrated solutions, cobas c 703  {Urea/BUN} 
CR260307 K972250 Urea (BUN) General Chemistry MODERATE 05/07/2026
Roche Diagnostics, cobas pro integrated solutions, cobas c 703  {Rheumatoid Factors II} 
CR260307 K032535 Rheumatoid factor (RF) General Immunology MODERATE 05/07/2026

-
-